Lab Publishes Generation of Human Choroid Scaffold for Cell Replacement Strategies Paper

Thursday, May 11, 2017 - 09:00

Age-related macular degeneration (AMD) is a devastating disease affecting more than 600 million people worldwide. Endothelial cells of the choriocapillaris (CECs) are among the first cell types lost in early AMD, and cell replacement therapy is currently the most promising option for restoring vision in patients with advanced AMD. In order to study CEC replacement strategies we have generated a 3D choroid scaffold using a novel decellularization method in human RPE/choroid tissue. To our knowledge, this is the first report describing decellularization of human RPE/choroid, as well as recellularization of a choroid scaffold with CECs. This work will aid in our development and optimization of cell replacement strategies using a tissue scaffold that is similar to the in vivo environment.

This work was published in Acta Biomaterialia (Acta Biomater. 2017 May 5. pii: S1742-7061(17)30294-5. doi: 10.1016/j.actbio.2017.05.011.).